Corneal Staining Clinical Trial
An investigational multi-purpose solution (MPS)was clinically evaluated against Biotrue MPS at specific time points over the course of four days. The study was conducted with PureVision lenses.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02251561 -
Clinical Evaluation of Opti-Free III (FID 109182) Compared to Opti-Free Plus® in Japan
|
N/A | |
Completed |
NCT01100424 -
Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining
|
N/A | |
Recruiting |
NCT05626478 -
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
|
Phase 4 | |
Recruiting |
NCT00381446 -
Evaluation of Corneal Staining With Various Contact Lens/Solution Combinations
|
N/A | |
Completed |
NCT01335750 -
A Clinical Comparison of Marketed Lens Care Solutions With Avaira Lens Brand
|
N/A | |
Completed |
NCT00483795 -
Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining
|
Phase 4 | |
Completed |
NCT00518700 -
Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients
|
Phase 4 |